Notebook

Baltimore Retraction Still In The Mail NAE Slow To Get The Message Tell Your Story To The World NSF Signs Lease On New Building On March 15, Nobel laureate David Baltimore, reacting to a draft of a National Institutes of Health report that criticized his behavior in the course of a five-year investigation of a scientific paper he coauthored when he was director of the Whitehead Institute for Biomedical Research at MIT (The Scientist, April 15, 1991, page 4), announced that he would retrac

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The new class of 84 members elected to the National Academy of Engineering is, not surprisingly, an illustrious one, including such well-known figures in the engineering world as supercomputing wizard Steve Chen and Hewlett-Packard Co. chief executive officer John Young. Unfortunately, another unsurprising fact is that the group of new inductees includes 83 men and only one woman: Union Carbide Corp. researcher Edith Flanigen.

Want to reach the masses on a hot issue of the day? David Jarmul, head of the op-ed service at the National Academy of Sciences in Washington, D.C., would be happy to hear from you. Since 1983 the academy has mailed out to newspapers across the country a weekly, 750-word commentary from a noted scientist. The average piece gets picked up by some 30 to 40 papers of varying sizes, says Jarmul, who has coordinated the project since its inception. Topics have included child care ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies